Skip to main content
Clinical Trials/NCT04405817
NCT04405817
Recruiting
Not Applicable

Outcome of Patients Treated With Extracorporeal Life Support

Nanjing Medical University1 site in 1 country300 target enrollmentJanuary 1, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiogenic Shock
Sponsor
Nanjing Medical University
Enrollment
300
Locations
1
Primary Endpoint
Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Registry
clinicaltrials.gov
Start Date
January 1, 2012
End Date
December 31, 2025
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Nanjing Medical University
Responsible Party
Principal Investigator
Principal Investigator

Hong Liu

Investigator of Department of Cardiac Surgery

Nanjing Medical University

Eligibility Criteria

Inclusion Criteria

  • Patients receiving ECMO for circulatory and/or respiratory support

Exclusion Criteria

  • Refusal of consent

Outcomes

Primary Outcomes

Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device

Time Frame: 30 days after ECMO implantation

Secondary Outcomes

  • All-cause mortality(12 months after ECMO implantation)

Study Sites (1)

Loading locations...

Similar Trials